EUROLAB
astm-f756-assessment-of-hemolytic-properties
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

ASTM F756 Assessment of Hemolytic Properties Laboratory Testing Service: A Comprehensive Guide

The ASTM F756 Assessment of Hemolytic Properties testing service is governed by a set of international and national standards that ensure the accuracy, reliability, and consistency of the results. The primary standard for this test is ASTM F756-12, which outlines the requirements for assessing the hemolytic properties of materials.

International Standards

  • ISO 10993-4:2002 Biological evaluation of medical devices -- Part 4: Selection of tests for interactions with blood

  • ISO 10993-5:2019 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity

  • ASTM F2110-07(2018) Standard Practice for Assessment of Hemolytic Properties of Materials

    • National Standards

  • EN ISO 10993-4:2002 Biological evaluation of medical devices -- Part 4: Selection of tests for interactions with blood (EU)

  • TSE EN ISO 10993-5:2019 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity (Turkey)

    • Standard Development Organizations

    The ASTM F756 standard is developed and maintained by the American Society for Testing and Materials (ASTM). The International Organization for Standardization (ISO) also plays a significant role in developing standards related to biological evaluation of medical devices.

    Evolution of Standards

    Standards evolve over time as new technologies, materials, and testing methods become available. The ASTM F756 standard is regularly updated to reflect changes in testing methodologies, equipment, and regulatory requirements.

    Standard Numbers and Scope

  • ASTM F756-12: Standard Practice for Assessment of Hemolytic Properties of Materials

    • Scope: This practice outlines the requirements for assessing the hemolytic properties of materials.

  • ISO 10993-4:2002 Biological evaluation of medical devices -- Part 4: Selection of tests for interactions with blood

    • Scope: This standard provides guidelines for selecting tests to assess the interaction between materials and biological fluids.

    Industry-Specific Standard Compliance Requirements

    Medical device manufacturers must comply with relevant standards, including ASTM F756, to ensure their products meet regulatory requirements. The following industries require compliance with this testing service:

  • Medical devices

  • Biomedical equipment

  • Implantable devices

  • Tissue engineering scaffolds

    • Standard-Related Information Conclusion

    The ASTM F756 Assessment of Hemolytic Properties testing service is governed by a set of international and national standards that ensure accuracy, reliability, and consistency. The primary standard for this test is ASTM F756-12, which outlines the requirements for assessing hemolytic properties.

    ---

    The ASTM F756 Assessment of Hemolytic Properties testing service is essential for ensuring product safety and compliance with regulatory requirements. This section explains why this specific test is needed and required.

    Business and Technical Reasons

    Conducting ASTM F756 Assessment of Hemolytic Properties testing is necessary for several reasons:

  • To ensure the safety of patients and users

  • To comply with regulatory requirements, such as those set by FDA (USA), EU MDR (EU), and ISO 10993 (International)

  • To meet industry-specific standard compliance requirements

    • Consequences of Not Performing This Test

    Failure to conduct this test can result in:

  • Product recalls due to safety concerns

  • Non-compliance with regulatory requirements, leading to fines or penalties

  • Loss of customer trust and reputation damage

    • Industries and Sectors that Require This Testing

    Medical device manufacturers, biotechnology companies, implantable device manufacturers, tissue engineering scaffold manufacturers, and biomedical equipment manufacturers require this testing service.

    Risk Factors and Safety Implications

    Hemolysis can occur when materials interact with biological fluids, leading to:

  • Blood clotting disorders

  • Hemolytic anemia

  • Transient or permanent damage to tissues

    • Conducting the ASTM F756 Assessment of Hemolytic Properties test helps identify potential risks and ensures product safety.

    Quality Assurance and Quality Control Aspects

    This testing service is essential for ensuring quality assurance and quality control:

  • Ensures accuracy, reliability, and consistency of results

  • Helps detect potential issues before product release

  • Supports regulatory compliance

    • Standard Requirements and Needs Conclusion

    The ASTM F756 Assessment of Hemolytic Properties testing service is essential for ensuring product safety and compliance with regulatory requirements. Conducting this test helps identify potential risks and ensures quality assurance and quality control.

    ---

    This section provides a detailed step-by-step explanation of how the ASTM F756 Assessment of Hemolytic Properties testing service is conducted.

    Testing Equipment and Instruments

    The following equipment and instruments are used:

  • Spectrophotometer

  • Centrifuge

  • Microscope

  • pH meter

  • Temperature control system

    • Testing Environment Requirements

    The test environment requires:

  • Controlled temperature (37C 1C)

  • Controlled humidity (40 to 60)

  • Ventilation system

    • Test Protocol

    The following steps are followed during the test:

    1. Preparation of materials and solutions

    2. Incubation of samples in a controlled environment

    3. Measurement of hemoglobin release

    4. Calculation of hemolysis ratio

    Data Analysis

    Results are analyzed using statistical methods, such as t-test and ANOVA.

    Test Conditions and Methodology Conclusion

    The ASTM F756 Assessment of Hemolytic Properties testing service is conducted using specialized equipment and instruments in a controlled environment.

    ---

    This comprehensive guide provides an overview of the ASTM F756 Assessment of Hemolytic Properties laboratory testing service.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers